Elevated Levels of Serum Tumor Markers CEA and CA15-3 Are Prognostic Parameters for Different Molecular Subtypes of Breast Cancer. by Yingbo Shao, Xianfu Sun, Yaning He, Chaojun Liu, Hui Liu

Get full text

Chinese version of exercise dependence scale-revised: psychometric analysis and exploration of risk factors by Yingbo Shao, Yingbo Shao, Haoyu Zhang, Haoyu Zhang, Xiaonan Zhang, Xiaonan Zhang, Qian Liang, Qian Liang, Hui Zhang, Hui Zhang, Feifei Zhang, Feifei Zhang

Get full text

Brain metastasis in de novo stage IV breast cancer by Yaning He, Yingbo Shao, Qi Chen, Chaojun Liu, Fangyuan Zhu, Hui Liu

Get full text

A real-world study of anlotinib as third-line or above therapy in patients with her-2 negative metastatic breast cancer by Yingbo Shao, Yingbo Shao, Zhifen Luo, Zhifen Luo, Yang Yu, Yang Yu, Yaning He, Yaning He, Chaojun Liu, Chaojun Liu, Qi Chen, Qi Chen, Fangyuan Zhu, Fangyuan Zhu, Bing Nie, Bing Nie, Hui Liu, Hui Liu

Get full text

HER2-low expression does not affect the clinical outcomes of metastatic breast cancer treated with CDK4/6 inhibitor: A real-world study by Yingbo Shao, Yingbo Shao, Zhifen Luo, Zhifen Luo, Yang Yu, Yang Yu, Qi Chen, Qi Chen, Yaning He, Yaning He, Chaojun Liu, Chaojun Liu, Bing Nie, Bing Nie, Fangyuan Zhu, Fangyuan Zhu, Hui Liu, Hui Liu

Get full text

Clinicopathological characteristics and value of HER2-low expression evolution in breast cancer receiving neoadjuvant chemotherapy by Yingbo Shao, Huijuan Guan, Zhifen Luo, Yang Yu, Yaning He, Qi Chen, Chaojun Liu, Fangyuan Zhu, Hui Liu

Get full text